Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.
Patients included in the registry will be contacted by telephone at 3,6,9, 12 months and 2, 5, 10 years after the procedure. In case coronary slow flow is shown at the index procedure, 39ml of blood will be drawn for further studies. According to the regulations of the Province Rheinland-Pfalz, national law, and with the approval of the Ethic commission of the Landesärztekammer Rheinland Pfalz, patients (n=1000) will also be retrospectively entered in the database in an anonymous way. For these patients, no specific study procedure is foreseen and the MICAT database will be only used as a platform (database of anonymous data collected during routine clinical practice).
Study Type
OBSERVATIONAL
Enrollment
1,000
University Medical Center Mainz - 2 Medizinische Klinik
Mainz, Germany
RECRUITINGMajor adverse cardiovascular events
Incidence of major adverse events (death, death of cardiac cause, TLR - target lesion revascularization, MI)
Time frame: baseline to 10 years
Individual endpoints
Each individual endpoint of the MACE previously described
Time frame: baseline to 10 years
Other cardiovascular endpoints
TVR - target vessel revascularization, re-hospitalization, change in medications.
Time frame: baseline to 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.